Position in MRK
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$7,791,063
+$952,006 QoQ
Shares Held
64,769
-0.3% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.08%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in MRK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026GAMCO INVESTORS, INC. ET AL holds $78,759,412 across 8 Drug Manufacturers - General names. MRK ranks #4 (9.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
26,339 | $24,225,822 | |
| 2 | JNJ |
Johnson & Johnson
|
80,414 | $19,656,398 | |
| 3 | PFE |
Pfizer Inc
|
589,634 | $16,556,922 | |
| 4 | MRK |
Merck & Co., Inc.
This page
|
64,769 | $7,791,063 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
87,058 | $5,280,067 | |
| 6 | ABBV |
AbbVie Inc.
|
15,124 | $3,289,318 | |
| 7 | AMGN |
Amgen Inc
|
5,023 | $1,767,342 | |
| 8 | GRFS |
Grifols SA
|
24,000 | $192,480 |
All Filings in MRK
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $7,791,063 | 64,769 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $6,839,057 | 64,973 | Shares | Sole | 2026-02-05 | |
| 2025-09-30 | $5,292,457 | 63,058 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $5,477,792 | 69,199 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $6,519,268 | 72,630 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $7,875,135 | 79,163 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $9,191,887 | 80,943 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $9,504,249 | 76,771 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $10,496,754 | 79,551 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $8,993,059 | 82,490 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $9,493,534 | 92,215 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $14,053,925 | 121,795 | Shares | Sole | 2023-08-15 | |
| 2023-03-31 | $13,664,731 | 128,440 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $18,227,420 | 164,285 | Shares | Sole | 2023-02-15 | |
| 2022-09-30 | $14,888,856 | 172,885 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $16,011,731 | 175,625 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $14,569,044 | 177,563 | Shares | Sole | 2022-05-18 | |
| 2021-12-31 | $13,560,145 | 176,933 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $13,489,455 | 179,596 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $14,684,609 | 188,821 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $14,128,883 | 192,075 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $9,358,368 | 119,897 | Shares | Sole | 2021-02-05 | |
| 2020-09-30 | $7,639,951 | 96,524 | Shares | Sole | 2020-11-06 | |
| 2020-06-30 | $2,840,107 | 38,490 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $6,012,990 | 81,903 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||